Hyperthermia Therapeutic Agent Delivery

Dr. Yousef Haik

Patent No./Application No.:

US/ 13/722,850

The side effects of conventional cancer treatments (chemotherapy), such as hair loss and nausea, are a big disadvantage to these methods. The completion of cancer treatment could be increased due to a high level of comfort if the effective agent could be deployed more specifically within the cancer cells.

The system employs a smart carrier that upon injection into the patients’ body will seek and home at the tumor site. A multifunctional particle has been developed to release a chemotherapeutic agent dose at the tumor site upon exposure to an electromagnetic field which significantly reduces the overall treatment dose.In addition of being a hyperthermia agent, the multifunctional particle can be remotely detected to help the treating physician in monitoring the effectiveness of the treatment noninvasively.

Unlike the conventional methods, this treatment enables:

• Localized deposition of chemotherapeutic agents directly into cancer tumor.

• Controlled release of the chemotherapeutic agents in intended areas only.

• Reduction of the described side effects.

• Noninvasive monitoring of the effectiveness of the treatment with chemotherapeutic agents.

• Medical applications (i.e. Cancer treatment)